antimycobacterial

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2016/06/26 07:05:17」(JST)

An antimycobacterial is a type of drug used to treat Mycobacteria infections.

Types include:

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 成人における非結核性抗酸菌による骨髄炎の治療 treatment of osteomyelitis due to nontuberculous mycobacteria in adults
2. 小児における非結核性抗酸菌性肺感染症の概要 overview of nontuberculous mycobacterial pulmonary infections in children
3. 小児における非結核性抗酸菌の皮膚および軟部組織感染症の概要 overview of nontuberculous mycobacterial skin and soft tissue infections in children
4. 小児における播種性非結核性抗酸菌（NTM）感染症およびNTM菌血症の概要 overview of disseminated nontuberculous mycobacterial ntm infections and ntm bacteremia in children
5. 小児における非結核性抗酸菌性リンパ節炎の概要 overview of nontuberculous mycobacterial lymphadenitis in children

Wang JF1, He WJ2, Zhang XX2, Zhao BQ2, Liu YH3, Zhou XJ4.
Bioorganic & medicinal chemistry letters.Bioorg Med Chem Lett.2015 Oct 1;25(19):4082-4. doi: 10.1016/j.bmcl.2015.08.034. Epub 2015 Aug 18.
A new dimeric sesquiterpene, dicarabrol (1), together with three known sesquiterpenes, carabrol (2), 11(13)-dehydroivaxillin (3), and 2-desoxy-4-epi-pulchellin (4), were isolated from the whole plant of Carpesium abrotanoides L. Their structures were elucidated on the basis of spectroscopic analysis
PMID 26316467

One-pot synthesis of new triazole-Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity.

Ramprasad J1, Nayak N1, Dalimba U2, Yogeeswari P3, Sriram D3.
Bioorganic & medicinal chemistry letters.Bioorg Med Chem Lett.2015 Oct 1;25(19):4169-73. doi: 10.1016/j.bmcl.2015.08.009. Epub 2015 Aug 8.
A new series of triazole-imidazo[2,1-b][1,3,4]thiadiazole hybrids (6a-s, 7a) were designed by a molecular hybridisation approach and the target molecules were synthesized via one pot click chemistry protocol. All the intermediates and final molecules were characterised using spectral methods and one
PMID 26298500

Re-engineering nalidixic acid's chemical scaffold: A step towards the development of novel anti-tubercular and anti-bacterial leads for resistant pathogens.

Peraman R1, Varma RV2, Reddy YP3.
Bioorganic & medicinal chemistry letters.Bioorg Med Chem Lett.2015 Oct 1;25(19):4314-9. doi: 10.1016/j.bmcl.2015.07.071. Epub 2015 Aug 1.
Occurrence of antibacterial and antimycobacterial resistance stimulated a thrust to discover new drugs for infectious diseases. Herein we report the work on re-engineering nalidixic acid's chemical scaffold for newer leads. Stepwise clubbing of quinoxaline, 1,2,4-triazole/1,3,4-oxadiazole with nalid
PMID 26277407